To Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for DementiaShimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research November 22, 2022November 22, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: To Develop Japan’s First Blood Biomarker-Based…Creating New Value from a New, Cutting-edge, Global…Roche announces positive data from broad blood…Proof of Concept of Diagnostic Aid Technology for…Proof of Concept of Diagnostic Aid Technology for…Strengthening Human Resource Training through a…
